MRUS - Merus prices equity offering at $28.5

Merus (NASDAQ:MRUS) has priced its offering of 3.86M shares of common stock at $28.50/share, for expected gross proceeds of ~$110.0M. Underwriters' over-allotment is an additional 578,947 shares. All of the shares in the offering are to be sold by Merus. Net proceeds will be used to advance the clinical development of its product candidates, for preclinical research and technology development, and for working capital and general corporate purposes. Closing date is November 9, 2021. Previously (Nov.04): Merus launches stock offering

For further details see:

Merus prices equity offering at $28.5